Courts On Botox Price Negotiations, Grant Terminations, More
By Gianna Ferrarin · November 3, 2026, 7:41 PM EST
A D.C. federal judge handed AbbVie a win on arguments that the Centers for Medicare & Medicaid Services wrongly selected its Botox drug for Medicare price negotiations....
To view the full article, register now.